H.R. 9225 requires the Administrator of the Federal Aviation Administration (FAA) to conduct a study to evaluate if certain aircraft, which are certified under part 23 of the Federal Aviation Regulations, can be utilized in commercial operations governed by part 121. This could potentially allow for a broader range of aircraft to be used in commercial passenger and cargo services.
Supporters of H.R. 9225 argue that the bill could enhance the efficiency of the aviation industry by expanding the types of aircraft that can be used for commercial operations. Proponents believe this could lead to increased competition and lower costs for consumers, as well as improved access to air travel in underserved regions.
Critics of H.R. 9225 express concerns about safety implications, suggesting that allowing more aircraft types into commercial operations could compromise passenger safety. There are worries that the study may overlook important regulatory standards that ensure the reliability and safety of aircraft in commercial service.
While there are no direct industry overlaps detected between the bill's subject matter and the sponsor's top donor industries, the lobbying activity in the aviation and healthcare sectors raises some concerns. Notably, Intermountain Health contributed $50,000 and Vertex Pharmaceuticals Incorporated contributed $60,000, both through lobbying firms. Although these contributions do not directly relate to aviation, they indicate a significant financial interest in federal regulations that could affect their operations. Voters should be aware that while the bill aims to assess aircraft certification, the financial influence of healthcare and infrastructure sectors could indirectly impact the outcomes of such studies.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | MARSHALL & POPP, LLC | $60,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | MARSHALL & POPP, LLC | $60,000 |
| INTERMOUNTAIN HEALTH | MCDERMOTT WILL & SCHULTE LLP | $50,000 |
| WAYFINDER GROUP (OBO RESEARCH CORPORATION OF THE UNIVERSITY OF HAWAII) | RED MAPLE CONSULTING, LLC | $40,000 |
| FRONTIER INFRASTRUCTURE HOLDINGS LLC | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| ECKERD CONNECTS | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| SMART APPROACHES TO MARIJUANA | OFF HILL STRATEGIES L.L.C. | $20,000 |
| FEDERATION OF ELECTRIC POWER COS OF JAPAN | GEORGE H. DENISON | $10,000 |
| MAYO CLINIC | MCDERMOTT WILL & SCHULTE LLP | undisclosed |
| VERIZON COMMUNICATIONS, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG TEN CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG 12 CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| SOUTHEASTERN CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| PAC-12 CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| ATLANTIC COAST CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Tracey Mann, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
